Keyword search
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (4)
All (4) ((4 results))
- 1. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005010Description:
This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.
Release date: 2005-04-29 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - 4. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (4)
Analysis (4) ((4 results))
- 1. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005010Description:
This paper looks into Canadian innovative biotechnology firms' access to financing capital. Results show that over 70% of biotech firms that attempted to raise financing capital were successful. Funds were primarily sought for R&D activities and came primarily from Canadian venture capitalists. Harsher market conditions were the main reasons put forward by investors to limit or reject biotechnology firms' funding requests.
Release date: 2005-04-29 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - 4. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: